Correlation Between Berkshire Hathaway and Medicus Pharma
Can any of the company-specific risk be diversified away by investing in both Berkshire Hathaway and Medicus Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Berkshire Hathaway and Medicus Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Berkshire Hathaway CDR and Medicus Pharma, you can compare the effects of market volatilities on Berkshire Hathaway and Medicus Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Berkshire Hathaway with a short position of Medicus Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Berkshire Hathaway and Medicus Pharma.
Diversification Opportunities for Berkshire Hathaway and Medicus Pharma
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Berkshire and Medicus is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Berkshire Hathaway CDR and Medicus Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicus Pharma and Berkshire Hathaway is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Berkshire Hathaway CDR are associated (or correlated) with Medicus Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicus Pharma has no effect on the direction of Berkshire Hathaway i.e., Berkshire Hathaway and Medicus Pharma go up and down completely randomly.
Pair Corralation between Berkshire Hathaway and Medicus Pharma
Assuming the 90 days trading horizon Berkshire Hathaway CDR is expected to under-perform the Medicus Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Berkshire Hathaway CDR is 10.88 times less risky than Medicus Pharma. The stock trades about -0.12 of its potential returns per unit of risk. The Medicus Pharma is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 325.00 in Medicus Pharma on September 15, 2024 and sell it today you would earn a total of 70.00 from holding Medicus Pharma or generate 21.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Berkshire Hathaway CDR vs. Medicus Pharma
Performance |
| Timeline |
| Berkshire Hathaway CDR |
| Medicus Pharma |
Berkshire Hathaway and Medicus Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Berkshire Hathaway and Medicus Pharma
The main advantage of trading using opposite Berkshire Hathaway and Medicus Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Berkshire Hathaway position performs unexpectedly, Medicus Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicus Pharma will offset losses from the drop in Medicus Pharma's long position.| Berkshire Hathaway vs. Canadian Imperial Bank | Berkshire Hathaway vs. Fairfax Financial Holdings | Berkshire Hathaway vs. iA Financial | Berkshire Hathaway vs. VersaBank |
| Medicus Pharma vs. Apple Inc CDR | Medicus Pharma vs. NVIDIA CDR | Medicus Pharma vs. Microsoft Corp CDR | Medicus Pharma vs. Amazon CDR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |